• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sanofi - American Depositary Shares (NQ:SNY)

    43.67 -0.62 (-1.40%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,426,342
    Open 44.02
    Bid (Size) 43.50 (300)
    Ask (Size) 43.92 (100)
    Prev. Close 44.29
    Today's Range 43.64 - 44.13
    52wk Range 42.33 - 52.68
    Shares Outstanding 1,250,690,553
    Dividend Yield 5.07%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now? ↗
    The stock looks cheap, but appearances can be deceiving. 
    Via The Motley Fool
    Topics Artificial Intelligence
    SANOFI-ADR (NASDAQ:SNY): A Quality Dividend Stock with a 5.31% Yield and Strong Fundamentals ↗
    Via Chartmill

    Performance

    YTD
    -9.5%
    -9.5%
    1 Month
    -5.1%
    -5.1%
    3 Month
    -10.3%
    -10.3%
    6 Month
    -12.4%
    -12.4%
    1 Year
    -16.6%
    -16.6%

    More News

    Read More
    News headline image
    1 Dirt Cheap Growth Stock to Buy Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
    Via The Motley Fool
    Sanofi (NASDAQ:SNY) Emerges as a Decent Value Pick with Strong Fundamentals ↗
    Via Chartmill
    Sanofi (NASDAQ:SNY): A High-Yield Dividend Stock with Strong Fundamentals and a 5.26% Payout ↗
    Via Chartmill
    News headline image
    Is This Biotech Stock a Buy After a Groundbreaking Approval? ↗
    Via The Motley Fool
    News headline image
    Recursion (RXRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Blackstone's $400 Million Bet on Teva: What Does the Smart Money Know That Most Investors Don't? ↗
    Via The Motley Fool
    Sanofi ADR (NASDAQ:SNY) Presents a Classic Value Investment Case ↗
    Via Chartmill
    News headline image
    Giants Costco, Sanofi, and SAP Raise Dividends by Over 10% ↗
    Via MarketBeat
    News headline image
    3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery ↗
    Via The Motley Fool
    Topics Intellectual Property World Trade
    News headline image
    Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
    From Regeneron Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth ↗
    Via The Motley Fool
    News headline image
    Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
    Via MarketMinute
    Topics Economy World Trade
    News headline image
    Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
    Via MarketMinute
    Topics Economy Government Lawsuit
    News headline image
    Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
    Via MarketMinute
    News headline image
    Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
    Via Finterra
    Topics Initial Public Offering
    News headline image
    Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
    Via MarketMinute
    News headline image
    AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
    Via MarketMinute
    News headline image
    The Brain Barrier Broken: Inside Denali Therapeutics’ Landmark FDA Approval of AVLAYAH
    Via Finterra
    Topics Economy Initial Public Offering
    News headline image
    Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
    From Regeneron Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Sanofi - American Depositary Shares publicly traded?
    Yes, Sanofi - American Depositary Shares is publicly traded.
    What exchange does Sanofi - American Depositary Shares trade on?
    Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Sanofi - American Depositary Shares?
    The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
    What is the current price of Sanofi - American Depositary Shares?
    The current price of Sanofi - American Depositary Shares is 43.67
    When was Sanofi - American Depositary Shares last traded?
    The last trade of Sanofi - American Depositary Shares was at 05/29/26 04:00 PM ET
    What is the market capitalization of Sanofi - American Depositary Shares?
    The market capitalization of Sanofi - American Depositary Shares is 54.62B
    How many shares of Sanofi - American Depositary Shares are outstanding?
    Sanofi - American Depositary Shares has 55B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.